⁯
=

Dear Editor,

Quercetin is an important flavonol among the members of six subclasses of flavonoid compounds. The name quercetin was derived from *quercetum* (after *Quercus*, i.e., oak), and has been used since 1857 (Fischer et al., 1997\[[@R21]\]). It has been named as 3,3′,4′,5,7-pentahydroxyflavone by the International Union of Pure and Applied Chemistry (IUPAC). It is also known by its synonym 3,3′,4′,5,7-pentahydroxy-2-phenylchromen-4-one (Li et al., 2016\[[@R33]\]). Quercetin is the most widely distributed and extensively studied flavonoid found in various food sources, including fruits, vegetables, nuts, wine, and seeds (Oboh et al., 2016\[[@R44]\]). Quercetin has various biological properties, including antioxidant, anti-inflammatory, antibacterial, antiviral, radical-scavenging, gastroprotective, and immune-modulatory activities (Anand David et al., 2016\[[@R6]\]; Massi et al., 2017\[[@R39]\]). In addition, in several recently-filed patents the wide therapeutic applications of quercetin and its derivatives have been described in detail (Chen et al., 2016\[[@R15]\]; Eid and Haddad, 2017\[[@R19]\]; Sharma et al., 2018\[[@R50]\]).

Quercetin exhibits a wide range of biological activities and therapeutic applications, which are of interest to the pharmaceutical, cosmetic, and food industries (Biler et al., 2017\[[@R10]\]). Here, we summarize the recent studies that have evaluated the biological and pharmacological activities of quercetin (Table 1[(Tab. 1)](#T1){ref-type="fig"}; References in Table 1: Abdelhalim et al., 2018\[[@R1]\]; Afifi et al., 2018\[[@R2]\]; Aghapour et al., 2018\[[@R3]\]; Ahmed et al., 2018\[[@R4]\]; Al-Asmari et al., 2018\[[@R5]\]; Ansar et al., 2016\[[@R7]\]; Atef et al., 2017\[[@R8]\]; Beghoul et al., 2017\[[@R9]\]; Calgarotto et al., 2018\[[@R11]\]; Chan et al., 2018\[[@R12]\]; Chang et al., 2017\[[@R13]\]; Chen et al., 2017\[[@R14]\]; Damiano et al., 2018\[[@R16]\]; Dong et al., 2017\[[@R17]\]; Duranti et al., 2018\[[@R18]\]; Esrefoglu et al., 2017\[[@R20]\]; Funakoshi et al., 2017\[[@R22]\]; Guo et al., 2017\[[@R23]\]; He et al., 2016\[[@R24]\]; Huang et al., 2017\[[@R25]\]; Jeon et al., 2017\[[@R26]\]; Ji et al., 2017\[[@R27]\]; Ju et al., 2018\[[@R28]\]; Kee et al., 2016\[[@R29]\]; Lan et al., 2017\[[@R30]\]; Lazo-Gomez and Tapia, 2017\[[@R31]\]; Li et al., 2018\[[@R32]\]; Liu and Zhou, 2017\[[@R34]\]; Liu et al., 2017\[[@R35]\]; Lu et al., 2018\[[@R36]\]; Maciel et al., 2016\[[@R37]\]; Maksymchuk et al., 2017\[[@R38]\]; Mitani et al., 2017\[[@R40]\]; Mkhize et al., 2017\[[@R41]\]; Naseer et al., 2017\[[@R42]\]; Pandya et al., 2017\[[@R45]\]; Patrizio et al., 2018\[[@R46]\]; Qin et al., 2017\[[@R47]\]; Ren et al., 2018\[[@R48]\]; Sameni et al., 2018\[[@R49]\]; Singh et al., 2018\[[@R51]\]; Sohn et al., 2018\[[@R52]\]; Tinay et al., 2017\[[@R53]\]; Veith et al., 2017\[[@R54]\]; Wu et al., 2018\[[@R55]\]; Xingyu et al., 2016\[[@R56]\]; Yang et al., 2017\[[@R57]\]; Yang et al., 2018\[[@R58]\]; Yarahmadi et al., 2017\[[@R60]\]; Yarahmadi et al., 2018\[[@R59]\]; Yazıcı et al., 2018\[[@R61]\]; Yuan et al., 2016\[[@R63]\]; Yuan et al., 2018\[[@R62]\]; Zhang et al., 2018\[[@R64]\]; Zhao et al., 2017\[[@R65]\]; Zhu et al., 2018\[[@R66]\]).
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